Starcef 200 mg (Cefixime) Capsules

Starcef 200 mg Cefixime Capsules by Beacon Pharmaceuticals for bacterial infections Orio Pharma

Starcef 200 mg (Cefixime) Capsules

5/5

Introduction:

Starcef 200 mg, manufactured by Beacon Pharmaceuticals Ltd and supplied by Orio Pharma, is a powerful broad-spectrum antibiotic used to treat a wide range of bacterial infections. Containing Cefixime, Starcef 200 mg belongs to the third generation of cephalosporins, known for its effectiveness against both Gram-positive and Gram-negative bacteria. This medication is particularly useful for treating infections of the respiratory tract, urinary tract, and other systemic infections, offering patients a reliable solution to combat bacterial illnesses.

Manufacturing Excellence of Beacon Pharmaceuticals Ltd.:

Beacon Pharmaceuticals Ltd. is committed to producing high-quality pharmaceutical products that adhere to stringent international standards. The development of Starcef 200 mg reflects Beacon’s dedication to advancing antibiotic treatments through innovative research, rigorous quality control, and adherence to best manufacturing practices. Their focus on safety and efficacy ensures that Starcef 200 mg is a reliable and effective option for managing bacterial infections.

Mechanism of Action:

Starcef 200 mg contains Cefixime, a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis. Cefixime binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which interferes with the final stages of peptidoglycan synthesis. This action weakens the bacterial cell wall, leading to cell lysis and ultimately, the death of the bacteria. This mechanism of action makes Starcef 200 mg effective against a wide variety of bacterial pathogens, including those resistant to other antibiotic classes.

Clinical Applications:

Starcef 200 mg is indicated for the treatment of:

  • Respiratory Tract Infections: Starcef 200 mg is effective in treating respiratory infections such as pneumonia, bronchitis, and sinusitis caused by susceptible bacteria.
  • Urinary Tract Infections (UTIs): Starcef 200 mg is commonly used to treat bacterial infections of the urinary tract, including cystitis and pyelonephritis.
  • Gonorrhea: Starcef 200 mg is also effective in treating uncomplicated gonorrhea caused by Neisseria gonorrhoeae.
  • Otitis Media: Starcef 200 mg is indicated for the treatment of otitis media, an infection of the middle ear, particularly in children.

Clinical studies and patient experience have shown that Cefixime is highly effective in treating these infections, providing rapid relief from symptoms and reducing the duration of illness.

Dosage and Administration:

The recommended dosage of Starcef 200 mg varies depending on the type and severity of the infection. Typically, the dosage is one 200 mg capsule taken once or twice daily, depending on the specific condition being treated. The capsules should be swallowed whole with water, and it is important for patients to complete the full course of antibiotics, even if symptoms improve before the medication is finished, to prevent the development of antibiotic-resistant bacteria.

Benefits of Starcef 200 mg:

  • Broad-Spectrum Antibiotic: Starcef 200 mg is effective against a wide range of bacteria, making it a versatile treatment option for various infections.
  • Rapid Symptom Relief: Starcef 200 mg provides quick relief from the symptoms of bacterial infections, helping patients recover more quickly.
  • Convenient Dosing: The flexibility of dosing allows for either once or twice-daily administration, depending on the infection being treated.
  • Well-Tolerated: Starcef 200 mg is generally well-tolerated, with a favorable safety profile when used according to the prescribed dosage and duration.

Supplier: Orio Pharma

Orio Pharma ensures that Starcef 200 mg is readily available to healthcare providers and patients, offering reliable access to this essential antibiotic treatment. Their commitment to efficient supply and distribution supports effective management of bacterial infections, helping to improve patient outcomes.

Conclusion:

Starcef 200 mg (Cefixime) by Beacon Pharmaceuticals Ltd, supplied by Orio Pharma, represents a trusted and effective solution for treating a wide range of bacterial infections. This broad-spectrum antibiotic offers fast and reliable relief from infection symptoms, helping patients recover quickly and prevent complications. By incorporating Starcef 200 mg into their treatment plans, healthcare providers can offer patients a dependable strategy for managing bacterial infections, ultimately leading to better health outcomes and reduced risk of antibiotic resistance.

 

Related Products